CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2017—ViroStat has introduced three Monotope monoclonal antibodies that are specific to Chlamydia pneumonia and do not cross-react with the related Chlamydia trachomatis and Chlamydia psittaci. They function in ELISA and IFA and are candidates for rapid test applications. The company also released three new Monotope monoclonal antibodies specific to EV71 (hand, foot, and mouth disease).
ViroStat, 207-856-6620